STOCK TITAN

Organon (OGN) HR chief converts 8,422 RSUs; 2,885 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Organon & Co. Chief Human Resources Officer Aaron Falcione exercised restricted stock units into common shares as part of his equity compensation. On March 29, 2026, 8,422 Restricted Stock Units converted into 8,422 shares of common stock at a conversion price of $0.00 per share.

To cover tax obligations, 2,885 of these shares were disposed of through a tax-withholding transaction at $5.84 per share, rather than through an open-market sale. After these transactions, Falcione directly held 89,646.071 shares of Organon common stock.

Each Restricted Stock Unit represents a right to receive one share of Organon common stock, and these awards vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027, aligning the executive’s compensation with the company’s long-term performance.

Positive

  • None.

Negative

  • None.
Insider Falcione Aaron
Role Chief Human Resources Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 8,422 $0.00 --
Exercise Common Stock 8,422 $0.00 --
Tax Withholding Common Stock 2,885 $5.84 $17K
Holdings After Transaction: Restricted Stock Units — 8,422 shares (Direct); Common Stock — 92,531.071 shares (Direct)
Footnotes (1)
  1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Each RSU represents a contingent right to receive one share of Organon common stock. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
RSUs exercised 8,422 units/shares Restricted Stock Units converted to common stock on March 29, 2026
Tax-withholding shares 2,885 shares Shares disposed to cover taxes on March 29, 2026
Tax-withholding price $5.84 per share Value used for tax-withholding disposition
Shares held after transaction 89,646.071 shares Direct Organon common stock ownership after March 29, 2026
Exercise price of RSUs $0.00 per unit Conversion price for 8,422 Restricted Stock Units
Restricted Stock Units financial
"This price is the closing market price ... under which the Restricted Stock Units ("RSU") were awarded."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
contingent right financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
vest financial
"These RSUs vest and are distributed as shares of Organon common stock in three equal installments..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Falcione Aaron

(Last)(First)(Middle)
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33

(Street)
JERSEY CITY NEW JERSEY 07302

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Human Resources Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/29/2026M8,422A$092,531.071D
Common Stock03/29/2026F2,885D$5.84(1)89,646.071D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)03/29/2026M8,422 (3) (3)Common Stock8,422$08,422D
Explanation of Responses:
1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
2. Each RSU represents a contingent right to receive one share of Organon common stock.
3. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Remarks:
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Aaron Falcione03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Organon (OGN) executive Aaron Falcione report in this Form 4?

Aaron Falcione reported an equity compensation event. 8,422 Restricted Stock Units converted into 8,422 Organon common shares, with some shares withheld to pay taxes. This reflects scheduled vesting rather than an open-market stock purchase or sale.

How many Organon (OGN) shares did Aaron Falcione acquire through RSU vesting?

He acquired 8,422 Organon common shares through Restricted Stock Unit conversion. These RSUs represent equity compensation that vests over time, aligning the executive’s interests with shareholders by tying part of his pay to Organon’s stock performance.

How many Organon (OGN) shares were withheld for taxes in this Form 4?

2,885 shares of Organon common stock were disposed of to satisfy tax obligations at $5.84 per share. This tax-withholding disposition is a standard mechanism and is not an open-market sale initiated for investment reasons.

What are the vesting dates of Aaron Falcione’s Organon (OGN) RSUs?

The Restricted Stock Units vest and are distributed as Organon common shares in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027, providing a staggered, long-term incentive structure for the executive.

How many Organon (OGN) shares does Aaron Falcione hold after these transactions?

Following the reported RSU conversion and tax-withholding disposition, Aaron Falcione directly holds 89,646.071 shares of Organon common stock. This reflects his updated equity stake after the March 29, 2026 compensation-related transactions.